{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:46:35Z","timestamp":1785732395703,"version":"3.56.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Atypical pulmonary carcinoid (AC) is a rare intermediate-grade neuroendocrine tumor with substantial clinical heterogeneity and an unpredictable prognosis. Accurate estimation of fixed-horizon mortality risk remains challenging because of its rarity and limited AC-specific prediction tools. This study aimed to develop and evaluate an interpretable model for estimating 3-year all-cause mortality in patients with AC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data for patients with AC diagnosed between 2000 and 2021 were retrospectively obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Patients diagnosed during 2000\u20132018 (n=1, 301) were randomly divided into a training set (n=910) and an internal test set (n=391). Patients diagnosed during 2019\u20132021 (n=446) constituted a temporal validation cohort within the same registry, and 45 patients treated at the General Hospital of Ningxia Medical University during 2015\u20132024 were used for preliminary independent single-center evaluation. Demographic, clinicopathological, and treatment variables were considered. LASSO regression and the Boruta algorithm selected 11 predictors: Grade, N_stage, M_stage, Bone_metastasis, Brain_metastasis, Liver_metastasis, Marital_status, Radiation, Chemotherapy, Age, and Tumor_Size. Seven machine learning models were developed to evaluate predictive performance, including Logistic Regression (LR), Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), Gradient Boosting Decision Tree (GBDT), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Adaptive Boosting (AdaBoost). The SHapley Additive exPlanations (SHAP) approach was used to interpret feature importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LR showed the most consistent held-out performance, with an area under the receiver operating characteristic curve of 0.802 (95% CI: 0.751\u20130.852) in the internal test set, 0.839 (95% CI: 0.796\u20130.882) in the temporal validation cohort, and 0.904 (95% CI: 0.808\u20131.000) in the single-center cohort. Boosting models showed larger declines from apparent training to held-out performance. Decision curve analysis (DCA) suggested potential net benefit across selected threshold probabilities. SHAP identified Age as the largest contributor to model predictions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The LR-based model showed consistent discrimination and interpretability in internal and same-registry temporal evaluation, with promising but imprecise results in the small single-center cohort. Geographic transportability remains unestablished. Independent multi-institutional validation with fully separated preprocessing is required before clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1901646","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:28:06Z","timestamp":1785731286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A dual-validated machine learning model for predicting 3-year mortality in atypical pulmonary carcinoid, a rare neuroendocrine tumor"],"prefix":"10.3389","volume":"17","author":[{"given":"Yong","family":"Chen","sequence":"first","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Luo","sequence":"additional","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Yang","sequence":"additional","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Ningxia Key Laboratory of Clinical and Pathogenic Microorganisms, Institute of Medical Science, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University","place":["Yinchuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00374-7","article-title":"Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies","volume":"26","author":"Sen","year":"2025","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000419","article-title":"Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis","volume":"10","author":"Steuer","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i5.106630","article-title":"Neuroendocrine neoplasms of the lung: the latest updates","volume":"16","author":"Orlandi","year":"2025","journal-title":"World J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12022-025-09886-9","article-title":"Digital immunophenotyping of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three subtypes with specific tumor-immune microenvironment features","volume":"36","author":"Centonze","year":"2025","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030502","article-title":"Prognostic thresholds of mitotic count and Ki-67 labeling index for recurrence and survival in lung atypical carcinoids","volume":"16","author":"Soldath","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3892\/ol.2023.13666","article-title":"Prognostic factors in resected pulmonary carcinoid tumors: a retrospective study with 10 years of follow-up","volume":"25","author":"Du","year":"2023","journal-title":"Oncol Lett"},{"key":"B7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lungcan.2019.11.006","article-title":"The role of surgery for atypical bronchopulmonary carcinoid tumor: development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database","volume":"139","author":"Chen","year":"2020","journal-title":"Lung Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-023-01465-4","article-title":"Percutaneous computed tomography-guided core needle biopsy can be used to histologically confirm the clinical features and long-term prognosis of pulmonary neuroendocrine neoplasms","volume":"41","author":"Chen","year":"2023","journal-title":"Jpn J Radiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.02.011","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for revision of the TNM stage groups in the forthcoming (ninth) edition of the TNM classification for lung cancer","volume":"19","author":"Rami-Porta","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6794","article-title":"Prognostic nomogram and epidemiological analysis for lung atypical carcinoid: a SEER database and external validation study","volume":"13","author":"Yi","year":"2024","journal-title":"Cancer Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ejcts\/ezu404","article-title":"Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group","volume":"48","author":"Filosso","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2023.104429","article-title":"A systematic review on machine learning approaches in the diagnosis and prognosis of rare genetic diseases","volume":"143","author":"Roman-Naranjo","year":"2023","journal-title":"J BioMed Inform"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman","year":"2018","journal-title":"J Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2022.11.003","article-title":"Machine learning for lung cancer diagnosis, treatment, and prognosis","volume":"20","author":"Li","year":"2022","journal-title":"Genomics Proteomics Bioinf"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101924","article-title":"Multimodal integration using a machine learning approach facilitates risk stratification in HR+\/HER2- breast cancer","volume":"6","author":"Zhang","year":"2025","journal-title":"Cell Rep Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40779-023-00488-2","article-title":"How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology","volume":"10","author":"Che","year":"2023","journal-title":"Mil Med Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/s23177407","article-title":"Sensor selection for tidal volume determination via linear regression-impact of lasso versus ridge regression","volume":"23","author":"Laufer","year":"2023","journal-title":"Sensors (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10238-025-01701-3","article-title":"LASSO regression and Boruta algorithm to explore the relationship between neutrophil percentage to albumin ratio and asthma: results from the NHANES 2001 to 2018","volume":"25","author":"Fu","year":"2025","journal-title":"Clin Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2022088","article-title":"The clinical meaning of the area under a receiver operating characteristic curve for the evaluation of the performance of disease markers","volume":"44","author":"Parodi","year":"2022","journal-title":"Epidemiol Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2017.11.018","article-title":"A discussion of calibration techniques for evaluating binary and categorical predictive models","volume":"149","author":"Fenlon","year":"2018","journal-title":"Prev Vet Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000542","article-title":"Variable importance analysis with interpretable machine learning for fair risk prediction","volume":"3","author":"Ning","year":"2024","journal-title":"PloS Digit Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol33010050","article-title":"Lung carcinoids\u2014time to change practices","volume":"33","author":"Rodrigues","year":"2026","journal-title":"Curr Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103591","article-title":"Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project","volume":"9","author":"Mathian","year":"2024","journal-title":"ESMO Open"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000001203","article-title":"Beyond the usual - atypical imaging presentation in lung cancer and implications for TNM-staging","volume":"38","author":"Kifjak","year":"2026","journal-title":"Curr Opin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.812276","article-title":"Comparing machine learning models and statistical models for predicting heart failure events: a systematic review and meta-analysis","volume":"9","author":"Sun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104813","article-title":"Interpretable prediction of 3-year all-cause mortality in patients with heart failure caused by coronary heart disease based on machine learning and SHAP","volume":"137","author":"Wang","year":"2021","journal-title":"Comput Biol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.09.029","article-title":"A national study of surgically managed atypical pulmonary carcinoid tumors","volume":"112","author":"Walters","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12885-021-07832-6","article-title":"Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors","volume":"21","author":"He","year":"2021","journal-title":"BMC Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jtho.2019.02.002","article-title":"Characterization, prognosis, and treatment of patients with metastatic lung carcinoid tumors","volume":"14","author":"Robelin","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.lungcan.2020.08.003","article-title":"Proposal of organ-specific subdivision of M component and staging system for metastatic pulmonary neuroendocrine tumor","volume":"148","author":"Wen","year":"2020","journal-title":"Lung Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03970-x","article-title":"Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis","volume":"149","author":"Zhang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.resmer.2026.101251","article-title":"Operated bronchial carcinoid tumors: impact of lymph node status and histological type on long-term outcomes","volume":"89","author":"Allili","year":"2026","journal-title":"Respir Med Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-446","article-title":"Impact of lymph node involvement in pulmonary carcinoids: a narrative review","volume":"13","author":"Dziedzic","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15319","article-title":"Incidence and prognostic nomogram for resected non-small cell neuroendocrine tumor: a population-based respective study in China and the SEER database","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2022.258","article-title":"Surgical approach of lung carcinoid tumors","volume":"18","author":"Nistor","year":"2022","journal-title":"Acta Endocrinol (Buchar)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172748","article-title":"Pulmonary carcinoids: diagnostic and therapeutic approach","volume":"17","author":"Petrella","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081753","article-title":"Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States","volume":"13","author":"Shah","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02346-x","article-title":"Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors","volume":"47","author":"La Salvia","year":"2024","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901646\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:28:07Z","timestamp":1785731287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1901646\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1901646"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1901646","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1901646"}}